ÂÜÀòÂÒÂ×

Klaus-Peter Adam is an accomplished professional in the field of technology and pharmaceuticals, currently serving as Chief Technology Officer at Precion since December 2019. With a strong background at Metabolon, Klaus-Peter has held multiple roles, including Manager and Associate Director of Targeted Assay Development, in addition to overseeing Diagnostics Assay Development from November 2007. Prior experience includes a position as Senior Staff Scientist at CEDRA Corporation from 2001 to 2007. Klaus-Peter holds a Ph.D. in Pharmacy from Universität des Saarlandes in Saarbrücken, Germany.